Patents Examined by Jacob A Boeckelman
  • Patent number: 11951145
    Abstract: The present invention relates to a composition for preventing or treating cancer, comprising extracts of Anemone raddeana and Lonicera species containing a high concentration of antitumor saponins, and a method for preparing the same, wherein saponins contained in the extracts of Anemone raddeana and Lonicera species, are converted to anticancer saponins having high antitumor activity, thereby producing extracts containing a high concentration of the antitumor saponins, and the extracts thus prepared have been confirmed to show desirable antitumor activity. Accordingly, the extracts containing a high concentration of antitumor saponins of the present invention are promising for use in the development of drugs for cancer treatment.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: April 9, 2024
    Inventor: Ju Youn Back
  • Patent number: 11944661
    Abstract: The present invention provides a pharmaceutical composition for prevention or treatment of a stress disease and depression, the pharmaceutical composition be safely useable without toxicity and side effects by using an extract of leaves of Vaccinium bracteatum Thunb., which is natural resource of Korea, so that the reduction of manufacturing and production costs and the import substitution and export effects can be expected through the replacement of a raw material for preparation with a plant inhabiting in nature.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: April 2, 2024
    Assignee: JEONNAM BIOINDUSTRY FOUNDATION
    Inventors: Chul Yung Choi, Dool Ri Oh, Yu Jin Kim, Eun Jin Choi, Hyun Mi Lee, Dong Hyuck Bae, Kyo Nyeo Oh, Myung-A Jung, Ji Ae Hong, Kwang Su Kim, Hu Won Kang, Jae Yong Kim, Sang O Pan, Sung Yoon Park, Rack Seon Seong
  • Patent number: 11944649
    Abstract: Provided herein are compositions, uses thereof, and methods for treating Autism or Autism Spectrum Disorder (ASD) in a subject in need thereof, wherein the compositions comprise a whey protein isolate and/or whey protein concentrate.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: April 2, 2024
    Assignee: IMMUNOTEC INC.
    Inventor: Ana Maria Castejon Semidey
  • Patent number: 11938161
    Abstract: The present disclosure belongs to the technical field of health care products or foods and provides the use of a ginseng alcohol extract in sleep-promoting health care products or foods. Through analysis utilizing DAM2 drosophila behavior monitoring system, it is found that the ginseng alcohol extract can increase total sleep duration of normal and sleep deprived drosophilae, and relieve sleep rhythm disorder caused by sleep deprivation. Through a climbing experiment, it is found that the ginseng alcohol extract can improve the climbing ability of normal and sleep deprived drosophilae. The ginseng alcohol extract, on the one hand, improves the quality of sleep to protect the steady state of sleep rhythm, and on the other hand, increases the motive ability after sleep. The ginseng alcohol extract of the present disclosure is intended to be used to sleep-promoting health care products or healthy foods and improve the quality of sleep.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: March 26, 2024
    Inventor: Liwei Sun
  • Patent number: 11931393
    Abstract: A biologically active food additive for normalizing the function of the thyroid gland comprises roots or rhizome or the above-ground part of white cinquefoil, or a mixture thereof, purple echinacca and laminaria, with the following ratio of components in mass %: 10-75 of white cinquefoil, 10-50 of purple echinacea and 10-80 of laminaria. The technical result of the invention is the showing of increased efficacy in treating thyroid gland disorders and enhancing the body's immune status, with no side of effects.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: March 19, 2024
    Assignee: Parapharm LLC
    Inventors: Vyacheslav N Trifonov, Yulia A. Elistratova, Konstantin G. Elistratov, Natalia V. Kurus'
  • Patent number: 11931389
    Abstract: The present invention provides a tablet of sporoderm-removed Ganoderma lucidum spore, which includes the following raw materials by weight parts: 13-20 parts of an aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, 3-5 parts of sorbitol, and 0.8-1.2 parts of povidone K30; A method for preparing the tablet of sporoderm-removed Ganoderma lucidum spore includes the following steps: mixing the aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, sorbitol and povidone K30 for 10-30 min, and subjecting the obtained mixture to granulating, screening and drying to obtain a granular material; and tableting the granular material to obtain the tablet of sporoderm-removed Ganoderma lucidum spore. The tablet of sporoderm-removed Ganoderma lucidum spore has a much higher content of active components, which are also easier to be absorbed.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: March 19, 2024
    Assignees: Zhejiang Shouxiangu Pharmaceutical Company, Ltd., Jinhua Shouxiangu Pharmaceutical Co. Ltd
    Inventors: Zhenhao Li, Mingyan Li, Ying Wang, Huaxian Zheng, Jing Xu
  • Patent number: 11911417
    Abstract: A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: February 27, 2024
    Assignee: LAIMU CORPORATION
    Inventors: Sachio Wakayama, Akihiro Tai
  • Patent number: 11865131
    Abstract: The present invention relates to a process for producing an extract powder from a fruit material of e.g. berry fruits, wherein anthocyanins are enriched from the fruit material, and to the product obtainable by the process. In the process according to the invention, anthocyanins are enriched via a cation exchanger. By eluting the anthocyanins from the cation exchanger by means of L-arginine, the process has the advantage that no salt needs to be purified from the eluate to produce an extract powder suitable for use as a dietary supplement.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: January 9, 2024
    Assignee: Deutsches Institut für Lebensmitteltechnik e.V.
    Inventor: Andreas Juadjur
  • Patent number: 11865106
    Abstract: The invention provides novel pharmaceutical compositions of berberine or a derivative or analog of berberine, or a salt thereof, in combination with one or more omega-3 fatty acids or esters thereof, and methods of their use in treating inflammatory bowel disease.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: January 9, 2024
    Assignee: SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD.
    Inventor: Liping Liu
  • Patent number: 11857586
    Abstract: The present invention relates to a composition for prevention or treatment of gynecological diseases containing an extract of Sarcodon imbricatus as an active ingredient. Specifically, the extract of Sarcodon imbricatus of the present invention can be effectively used, with only one dose, for prevention or treatment of gynecological diseases by treating dysmenorrhea, reducing a menstrual period, an amount of menstruation, menstrual irregularity, and extravasated blood, and clearing the color of menstruation.
    Type: Grant
    Filed: October 11, 2022
    Date of Patent: January 2, 2024
    Inventor: Hye Jin Woo
  • Patent number: 11857578
    Abstract: The invention relates to a new bacterial extract that can be used for protecting and/or treating sensitive skin and/or reactive, intolerant skin, particularly by means of targeted action on neurogenic inflammation of the skin. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial extract as an active ingredient.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: January 2, 2024
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Nathalie Castex-Rizzi, Bertrand Chol, Fabrice Lestienne
  • Patent number: 11850297
    Abstract: A composition containing a combination of exosomes and sapogenin as an active ingredient is disclosed. The composition is able to promote preadipocyte proliferation, lipid uptake into adipocytes, and/or adipogenesis, but reduce the cytotoxicity caused by sapogenin. Therefore, the composition can reduce side effects on the body or skin, and can be used such that it is conveniently applied to a dissatisfactory part of the body showing flaws which look less plump due to a deficit in lipids and the like, or an area of the skin showing flaws caused by a deficit in lipids.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: December 26, 2023
    Assignee: ExoCoBio Inc.
    Inventors: Yong Weon Yi, Byong Seung Cho
  • Patent number: 11833183
    Abstract: A method for improving body shape and improving skin condition using a noni fruit ferment is provided, and the method includes: administrating a composition to a subject in need thereof. The composition includes an effective amount of noni fruit ferment. The noni fruit ferment is prepared by (a) mixing glucose and noni fruit with water for extraction, to obtain a noni fruit broth, and (b) fermenting the noni fruit broth with a plurality of bacteria strains. The bacteria strains include yeast, lactic acid bacteria, and acetic acid bacteria. In step (b), the noni fruit broth and the bacteria strains are irradiated with a red light source with a wavelength of 620 nm to 750 nm. In addition, the noni fruit ferment also has at least one of the following functions: removing free radicals, improving defecation status, and improving gastrointestinal motility.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: December 5, 2023
    Assignee: TCI CO., LTD.
    Inventors: Yung-Hsiang Lin, Pei-Yi Wu
  • Patent number: 11793851
    Abstract: The present invention relates to a method for treating a side effect caused by bacillus Calmette-Guérin (BCG) perfusion therapy for bladder cancer. The method includes: administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising Gentiana scabra, Scutellariae Radix, Gardeniae Fructus, Angelicae Sinensis Radix, Rehmanniae radix, Akebiae Caulis, Bupleurum chinense, Plantaginis Semen, Atractylodes lancea, Rhizoma alismatis, and Glycyrrhiza uralensis.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: October 24, 2023
    Inventor: Chen-Yu Lee
  • Patent number: 11793846
    Abstract: Disclosed is a method for preparing bitter Ganoderma lucidum spore powder, and relates to the field of drugs or health care products. The method includes: removing visible impurities from Ganoderma lucidum spores, conducting ice bath and heating extraction, filtering through a microfiltration membrane, sterilizing by drying, and conducting sporoderm disruption to obtain the bitter Ganoderma lucidum spore powder. The preparation method effectively improves the content of the bitter substances in the Ganoderma lucidum spore powder by removing shriveled spores through multiple times of impurity removal and filtration in combination with the manner of conducting sporoderm disruption after extraction. Taking the total Ganoderma lucidum triterpenoids in the Ganoderma lucidum spores as a representative of the bitter substances, the content of the total Ganoderma lucidum triterpenoids can reach 5-8%. Meanwhile, the preparation method can also make the content of Ganoderma lucidum polysaccharides reaching 6-10%.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: October 24, 2023
    Assignees: Zhejiang Shouxiangu Pharmaceutical Company, Ltd, Jinhua Shouxiangu Pharmaceutical Co. Ltd
    Inventors: Zhenhao Li, Jing Xu, Ying Wang, Yuejiao Shi, Mingyan Li
  • Patent number: 11779620
    Abstract: Described herein are combined fungal compositions for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that causes an inflammatory response. In one aspect the composition comprises an aqueous or solid fraction of Trametes versicolor and Fomitopsis officinalis mycelium, fermented substrates thereof, or combinations thereof.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: October 10, 2023
    Assignee: TURTLE BEAR HOLDINGS, LLC
    Inventor: Paul E. Stamets
  • Patent number: 11779626
    Abstract: The present invention relates to a composition for enhancing immunity or a composition for preventing or ameliorating neurodegenerative diseases, both of which contain, as an active ingredient, a mixture extract of goji berries, mulberries and jujubes or an extract mixture thereof.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: October 10, 2023
    Assignee: COSMAX NS, INC.
    Inventors: Kwang Soo Baek, Hyunji Kim, Su Young Choi, Jin Hak Kim, Jae Seok Shim, Young Min Park, Sang Woo Kim, Mann-Seok Yoon, Yoon Jong Lee
  • Patent number: 11730784
    Abstract: Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: August 22, 2023
    Assignee: TURTLE BEAR HOLDINGS, LLC
    Inventor: Paul E. Stamets
  • Patent number: 11690888
    Abstract: The present invention relates to a composition for preventing or treating menopausal syndrome, containing a medicinal herb extract as an active ingredient. The composition has effects of alleviating heart function deterioration and depression, which are caused by menopause, and has biostability, thereby being usable as a composition for preventing or treating female menopausal syndrome.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: July 4, 2023
    Assignees: DONGGUK UNIVERSITY WISE CAMPUS INDUSTRY-ACADEMY COOPERATION FOUNDATION, KOREA PHARMA CO., LTD.
    Inventors: Dong Il Kim, Song Hee Jeon, Seung Hee Han, Kwang Suk Lee
  • Patent number: 11672266
    Abstract: The present invention relates to a process for producing an ethanol-free vanilla extract, and an ethanol-free vanilla extract obtainable by the process according to the invention. In particular, the present invention relates to an ethanol-free vanilla extract comprising at most 100 mg/kg ethanol, the use of this ethanol-free vanilla extract and products comprising the ethanol-free vanilla extract. The focus of the present invention is in particular to provide an ethanol-free vanilla extract which contains only traces of ethanol naturally contained in fermented vanilla beans and is produced without the use of ethanol.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: June 13, 2023
    Assignee: SYMRISE AG
    Inventors: Johannes Kiefl, Stefan Brennecke, Martin Heinemeyer, Dominik Winkler